Cleveland Clinic Cancer Center Independence
Independence, Ohio, United States
Cancer treatment center in Independence, Ohio
5001 Rockside Rd, Independence, OH 44131
About Cleveland Clinic Cancer Center Independence
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
39
SWOG Cancer Research Network
18
NRG Oncology
9
Alliance for Clinical Trials in Oncology
5
ECOG-ACRIN Cancer Research Group
5
Radiation Therapy Oncology Group
5
NSABP Foundation Inc
2
Eastern Cooperative Oncology Group
1
National Heart, Lung, and Blood Institute (NHLBI)
1
Clinical Trials at Cleveland Clinic Cancer Center Independence
During the past decade, Cleveland Clinic Cancer Center Independence conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 43 clinical trials were completed, i.e. on
average, 143.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 28 clinical trials were completed. i.e. 933.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
2005-06-01
2012-08-01
Completed
823
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Independence" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "SWOG Cancer Research Network" with 18 trials
sponsored, "NRG Oncology" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 5 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Independence"
#1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Radiation Therapy Oncology Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Cleveland Clinic Cancer Center Independence
According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Cancer Center Independence" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (6 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Cleveland Clinic Cancer Center Independence" in a lesser frequency.
Clinical Trials Intervention Types at Cleveland Clinic Cancer Center Independence
Most popular intervention types in "Cleveland Clinic Cancer Center Independence" are "Drug" (69 trials), "Other" (56 trials), "Biological" (29 trials), "Radiation" (27 trials) and "Procedure" (12 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (19 trials), "Cisplatin" (12 trials), "Carboplatin" (11 trials) and "Paclitaxel" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Cleveland Clinic Cancer Center Independence
The vast majority of trials in "Cleveland Clinic Cancer Center Independence" are
70 trials for "All" genders, 9 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Cleveland Clinic Cancer Center Independence
Currently, there are NaN active trials in "Cleveland Clinic Cancer Center Independence".
undefined are not yet recruiting,
16 are recruiting,
42 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Cleveland Clinic Cancer Center Independence,
1 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Cleveland Clinic Cancer Center Independence, 2 "Phase 1"
clinical trials were conducted, 33 "Phase 2" clinical
trials and 58 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".